Member Info for Geovanni

Thank you Wigster77 for uploading the video of the question asked to JVT about the Synairgen treatment. His answer was very classy and matches his actions of the previous week . That is why he got to the top of his profession. When the Panorama documentary comes out later this year dedicated to the story of the development of the Synairgen wonder treatment, that video clip will be in the program.

Thankyou ADF for this information about the TV programme.

Correct link now attached
https://www.pharmaceutical-technology.com/news/brii-biosciences-eua-us-fda-covid-19-combination/

https://www.nih.gov/research-training/medical-research-initiatives/activ/covid-19-therapeutics-prioritized-testing-clinical-trials#activ2

EUA still not approved in USA

And the active comparator in ACTIV 2 Phase 3 is the neutralising antibody made by Regeneron that doesn't work on Omicron. Leaving 3 treatments only that are effective. These being GSK/VIR Sotrovimab, SAB 185 and SNG001 .

Topsharepicks. Put your £25k in Synairgen. Phase 3 clinical trial results of their inhaled inteferon beta 1a covid treatment will be announced any day. The results will be very good. Why else has the company advertised just yesterday multiple senior positions in USA when currently they have no staff there and only around 30 employees in total. Soon the whole world will know about this company. I have a big shareholding in Beowulf but my shareholding in Synairgen is 4 times larger. Enjoy the ride

You seem to mean well Eric, but I think you need to do some homework. You can find plenty of info on the internet about how to value mining companies. Tops has done his home work and so have I.

The clue is in the size of the reserves and the price of iron ore. 50p is conservative

https://www.bbc.co.uk/sounds/play/w3ct1l4w

Broadcast today at 9.30am. Includes an interview with VIR Technology researchers

Well in excess of 50p for Kallak as there will be competition from the likes of Rio Tinto. Meanwhile just enjoy this beautiful ride everybody.

plus 17%

When can we expect an apology of lbjj. Time for a sweepstake?

14.5p in Sweden based on 12.35 SEK= £1
Discount of 14% on AIM with a buy price of 12.5p. When LKAB (or other) agree a takeover price the differential will vanish as UK holders will be paid the agreed SEK price converted to sterling.

lbjj - it only took you five minutes to be proven wrong this morning. That is a new record

It will be found there

https://www.riksdagen.se/sv/dokument-lagar/dokument/interpellationsdebatt/be****-om-kallak_H910191

https://www.washingtonpost.com/health/2022/01/10/covid-hospitalized-omicron/?utm_campaign=wp_post_most&utm_medium=email&utm_source=newsletter&wpisrc=nl_most&carta-url=https%3A%2F%2Fs2.washingtonpost.com%2Fcar-ln-tr%2F35bae0d%2F61ddb7699d2fda14d7eacbc9%2F61cf3cc6ade4e20c8a75fe0a%2F12%2F72%2F61ddb7699d2fda14d7eacbc9

Our friendly swedish native speaker can advise. I hope he will enlighten us all once again.

Up 6% in Sweden. We are now at at an 18% discount at 11.11p to buy. Congrats to you canny patient investors. That gap has to close very soon.

The fact that Synairgen gets a special section of its own at the end of the Hardman report says it all. The author of this report has to display a cautious approach. If he was as excited about the potential as most of us are and it all goes pear-shaped then he will have more to worry about than his own personal investment. He has a career to worry about.

Canny investors can join the dots and if they hadn't heard of Synairgen before reading this Hardman report then they'll be doing their own research now.